Health Monitor Malta: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Monitor Malta.

Press releases published on July 21, 2026

Jul. 21, 2026

Vaxart to Participate in BTIG Biotechnology Conference 2026

Indeterminate GlobeNewswire

Jul. 21, 2026

Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule

Indeterminate GlobeNewswire

Jul. 21, 2026

PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada

Indeterminate GlobeNewswire

Jul. 21, 2026

Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles

Indeterminate GlobeNewswire

Jul. 21, 2026

Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®

Indeterminate GlobeNewswire

Jul. 21, 2026

Applied Biologics Initiates Multi-Center Real-World Outcomes Study of XWRAP® Across Chronic Wound Types

Indeterminate GlobeNewswire

Jul. 21, 2026

Kraig Biocraft Laboratories CEO Kim Thompson Featured in Just Style, a Leading Global Apparel Industry Trade Publication

Indeterminate GlobeNewswire

Jul. 21, 2026

Axiom Biosciences Announces Intention to Become the First U.S. Biotech to List on the Hong Kong Stock Exchange

Indeterminate GlobeNewswire

Jul. 21, 2026

R1 Therapeutics announces commencement of global Phase 2b trial of AP306 for hyperphosphatemia in patients on dialysis

Indeterminate GlobeNewswire

Jul. 21, 2026

PharmAla Biotech Executes Definitive License Agreement Granting Jupiter Neurosciences Exclusive U.S. Rights to ALA-002

Indeterminate GlobeNewswire

Jul. 21, 2026

Aclarion Announces Presentation of Two Abstracts Highlighting Nociscan’s Growing Role in Real-World Clinical Practice

Indeterminate GlobeNewswire

Jul. 21, 2026

Tempest Announces Development Collaboration with Senlang Biotechnology for TPST-4003, a CD7-Targeted Next-Generation In Vivo CAR-T

Indeterminate GlobeNewswire

Jul. 21, 2026

Agios Provides Update on Phase 2 Trial of Tebapivat in Sickle Cell Disease

Indeterminate GlobeNewswire

Jul. 21, 2026

OKYO Pharma Announces Purchase of Shares by Chairman

Indeterminate GlobeNewswire

Jul. 21, 2026

BioNTech veröffentlicht am 4. August 2026 Ergebnisse für das zweite Quartal 2026 und informiert über operativen Fortschritt

Indeterminate GlobeNewswire

Jul. 21, 2026

Allogenetics Appoints Dr. Jeroen Rovers as Chief Medical Officer

Indeterminate GlobeNewswire

Jul. 21, 2026

OMEICOS’ OMT-28 Headed for Phase 3 in Primary Mitochondrial Diseases (PMD) Following Positive End-of-Phase 2 Meeting with the FDA

Indeterminate GlobeNewswire